Initial failures of anti-tau antibodies in Alzheimer's disease are reminiscent of the amyloid-β story
Neural Regen Res
.
2023 Jan;18(1):117-118.
doi: 10.4103/1673-5374.340409.
Authors
Bruno P Imbimbo
1
,
Claudia Balducci
2
,
Stefania Ippati
3
,
Mark Watling
4
Affiliations
1
Department of Research & Development, Chiesi Farmaceutici, Parma, Italy.
2
Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy.
3
San Raffaele Scientific Institute, San Raffaele Hospital, Milan, Italy.
4
CNS & Pain Department, TranScrip Ltd., Reading, UK.
PMID:
35799522
PMCID:
PMC9241406
DOI:
10.4103/1673-5374.340409
No abstract available